Infection in Organ Transplantation
- PMID: 28117944
- DOI: 10.1111/ajt.14208
Infection in Organ Transplantation
Abstract
The prevention, diagnosis, and management of infectious disease in transplantation are major contributors to improved outcomes in organ transplantation. The risk of serious infections in organ recipients is determined by interactions between the patient's epidemiological exposures and net state of immune suppression. In organ recipients, there is a significant incidence of drug toxicity and a propensity for drug interactions with immunosuppressive agents used to maintain graft function. Thus, every effort must be made to establish specific microbiologic diagnoses to optimize therapy. A timeline can be created to develop a differential diagnosis of infection in transplantation based on common patterns of infectious exposures, immunosuppressive management, and antimicrobial prophylaxis. Application of quantitative molecular microbial assays and advanced antimicrobial therapies have advanced care. Pathogen-specific immunity, genetic polymorphisms in immune responses, and dynamic interactions between the microbiome and the risk of infection are beginning to be explored. The role of infection in the stimulation of alloimmune responses awaits further definition. Major hurdles include the shifting worldwide epidemiology of infections, increasing antimicrobial resistance, suboptimal assays for the microbiologic screening of organ donors, and virus-associated malignancies. Transplant infectious disease remains a key to the clinical and scientific investigation of organ transplantation.
Keywords: clinical research/practice; complication: infectious; fungal; immunosuppression/immune modulation; infection and infectious agents; infectious disease; microbiomics; organ transplantation in general; viral.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.
Similar articles
-
Opportunistic infections--coming to the limits of immunosuppression?Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a015669. doi: 10.1101/cshperspect.a015669. Cold Spring Harb Perspect Med. 2013. PMID: 24086067 Free PMC article. Review.
-
Infection in renal transplant recipients.Semin Nephrol. 2007 Jul;27(4):445-61. doi: 10.1016/j.semnephrol.2007.03.006. Semin Nephrol. 2007. PMID: 17616276 Review.
-
From the classic concepts to modern practice.Clin Microbiol Infect. 2014 Sep;20 Suppl 7:4-9. doi: 10.1111/1469-0691.12593. Clin Microbiol Infect. 2014. PMID: 24528498 Review.
-
Urinary tract infections after renal transplantation.Curr Opin Urol. 2002 Mar;12(2):125-30. doi: 10.1097/00042307-200203000-00007. Curr Opin Urol. 2002. PMID: 11859258 Review.
-
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".Clin Infect Dis. 2021 Oct 5;73(7):e1302-e1317. doi: 10.1093/cid/ciaa1189. Clin Infect Dis. 2021. PMID: 32803228 Free PMC article. Review.
Cited by
-
Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis.Stem Cell Res Ther. 2021 Mar 1;12(1):158. doi: 10.1186/s13287-021-02219-7. Stem Cell Res Ther. 2021. PMID: 33648596 Free PMC article.
-
Epigenetic reprogramming of host and viral genes by Human Cytomegalovirus infection in Kasumi-3 myeloid progenitor cells at early times post-infection.J Virol. 2021 May 10;95(11):e00183-21. doi: 10.1128/JVI.00183-21. Epub 2021 Mar 17. J Virol. 2021. PMID: 33731453 Free PMC article.
-
Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models.Sci Rep. 2022 May 4;12(1):7298. doi: 10.1038/s41598-022-11290-w. Sci Rep. 2022. PMID: 35508582 Free PMC article.
-
Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial.BMC Infect Dis. 2018 Nov 15;18(1):573. doi: 10.1186/s12879-018-3493-y. BMC Infect Dis. 2018. PMID: 30442095 Free PMC article. Clinical Trial.
-
Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs.Clin Microbiol Rev. 2019 Sep 11;32(4):e00042-19. doi: 10.1128/CMR.00042-19. Print 2019 Sep 18. Clin Microbiol Rev. 2019. PMID: 31511250 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical